Breaking News Instant updates and real-time market news.

ATRS

Antares Pharma

$2.89

0.29 (11.15%)

07:03
08/07/18
08/07
07:03
08/07/18
07:03

Antares Pharma reports Q2 EPS (3c), consensus (2c)

Reports Q2 revenue $14.2M, consensus $13.25M.

  • 07

    Aug

  • 29

    Sep

ATRS Antares Pharma
$2.89

0.29 (11.15%)

05/08/18
HCWC
05/08/18
NO CHANGE
Target $4
HCWC
Buy
Antares target raised to $4 on higher Xyosted confidence at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat said that Antares Pharma reported "solid" Q1 results but "most importantly...finally explicitly confirmed a key aspect of the Xyosted filing," specifically that the company already conducted an ambulatory blood pressure monitoring study as part of the supplemental safety study ahead of the NDA submission. That fact, along with Antares' ability to re-submit the NDA just a week after receiving the minutes from the FDA Type-A meeting, increases his confidence in Xyosted approval coming in 2018, Livnat said. He raised his view of Xyosted's probability of success to 70% from 40% and increased his price target to $4 from $3.50 on Antares shares. Livnat keeps a Buy rating on the stock.
10/23/17
JANY
10/23/17
NO CHANGE
JANY
Neutral
Antares CRL doesn't raise issues for Amag Pharmaceuticals, says Janney Capital
Janney Capital analyst Ken Trbovich noted that the FDA complete response letter issued to Antares (ATRS) for Xyosted did not pertain to the Quickshot subcutaneous autoinjector, which raises his confidence the FDA will not identify such issues as a short coming of the sNDA for Amag Pharmaceuticals' (AMAG) Makena SQ. However, he keeps a Neutral rating on Amag shares, noting that the primary uncertainty for the sNDA for Makena SQ is the fact that its peak plasma levels is higher than the upper bound the FDA uses to define bioequivalence.
10/23/17
RAJA
10/23/17
NO CHANGE
Target $3.4
RAJA
Strong Buy
Antares Pharma maintained as a Strong Buy at Raymond James
Raymond James analyst Elliot Wilbur said the FDA's CRL on Antares Pharma (ATRS) XYOSTED was an unexpected and significant setback, but weakness in shares since the October disclosure effectively prices XYOSTED at zero, and substantially undervalues other development programs, especially ANDA products with Teva (TEVA). Wilbur is not writing-off XYSTED yet and is pushing out an expected launch to 2H19 from early 2018 previously, and is now discounting the probability of success at 50% versus 100% prior to the CRL. The analyst maintains asset values for Antares' non-XYOSTED assets are worth $2.50 per share using a sum-of-the-parts valuation and adjusted his price target to $3.40 from $4.20 on shares. Wilbur maintains a Strong Buy rating on Antares
10/23/17
MSCO
10/23/17
NO CHANGE
Target $26
MSCO
Overweight
Antares CRL should have limited read through to Amag, says Morgan Stanley
After Antares Pharma (ATRS) announced that it has received a FDA complete response letter about the new drug application for Xyosted due to two deficiencies related to clinical data, Morgan Stanley analyst Thomas Smith said the CRL should have limited read through to Amag Pharmaceuticals (AMAG), which has partnered with Antares for technology being used in subcutaneous Makena. The CRL is not related to the device or manufacturing, noted Smith, who adds that investor relief over the minimal Makena read through could lead to a rally in Amag shares following the recent weakness. He keeps 60% probability of success for Makena SC and maintains an Overweight rating on Amag shares.

TODAY'S FREE FLY STORIES

SFS

Smart & Final Stores

$4.96

-0.2 (-3.88%)

16:25
11/14/18
11/14
16:25
11/14/18
16:25
Hot Stocks
Smart & Final Stores reports Q3 gross margin up 8.7% y/y »

Gross margin was $232.4M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

FIS

FIS

$104.57

-0.26 (-0.25%)

16:25
11/14/18
11/14
16:25
11/14/18
16:25
Initiation
FIS initiated  »

FIS initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

16:25
11/14/18
11/14
16:25
11/14/18
16:25
Conference/Events
Federal Reserve Bank of Dallas president participates in a discussion »

Federal Reserve Bank of…

KBH

KB Home

$20.80

-0.135 (-0.64%)

16:25
11/14/18
11/14
16:25
11/14/18
16:25
Conference/Events
KB Home to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

YUMA

Yuma Energy

$0.29

-0.0088 (-2.98%)

16:24
11/14/18
11/14
16:24
11/14/18
16:24
Hot Stocks
Yuma Energy retains Seaport Global to explore alternatives, liquidity options »

Yuma Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDC

First Data

$17.83

-0.18 (-1.00%)

16:24
11/14/18
11/14
16:24
11/14/18
16:24
Initiation
First Data initiated  »

First Data initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 03

    Mar

FISV

Fiserv

$77.75

0.09 (0.12%)

16:24
11/14/18
11/14
16:24
11/14/18
16:24
Initiation
Fiserv initiated  »

Fiserv initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLT

FleetCor

$190.96

-3.61 (-1.86%)

16:23
11/14/18
11/14
16:23
11/14/18
16:23
Initiation
FleetCor initiated  »

FleetCor initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPN

Global Payments

$107.30

-1.26 (-1.16%)

16:22
11/14/18
11/14
16:22
11/14/18
16:22
Initiation
Global Payments initiated  »

Global Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SFS

Smart & Final Stores

$4.96

-0.2 (-3.88%)

16:22
11/14/18
11/14
16:22
11/14/18
16:22
Earnings
Smart & Final Stores raises FY18 adjusted EPS view to 46c-48c from 42c-47c »

FY18 consensus 44c.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

GDOT

Green Dot

$80.73

1.57 (1.98%)

16:22
11/14/18
11/14
16:22
11/14/18
16:22
Initiation
Green Dot initiated  »

Green Dot initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MA

MasterCard

16:22
11/14/18
11/14
16:22
11/14/18
16:22
Initiation
MasterCard initiated  »

MasterCard initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

MGI

MoneyGram

$2.14

-0.09 (-4.04%)

16:21
11/14/18
11/14
16:21
11/14/18
16:21
Initiation
MoneyGram initiated  »

MoneyGram initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDTI

CDTi

$1.49

-0.03 (-1.97%)

16:21
11/14/18
11/14
16:21
11/14/18
16:21
Earnings
CDTi reports Q3 EPS (37c) vs. (11c) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAYX

Paychex

$66.72

-1.03 (-1.52%)

16:21
11/14/18
11/14
16:21
11/14/18
16:21
Initiation
Paychex initiated  »

Paychex initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBER

Uber

$0.00

(0.00%)

16:20
11/14/18
11/14
16:20
11/14/18
16:20
Periodicals
Uber reports nearly $1B loss in Q3, CNBC says »

Uber reported a nearly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$84.05

0.26 (0.31%)

16:20
11/14/18
11/14
16:20
11/14/18
16:20
Initiation
PayPal initiated  »

PayPal initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 26

    Nov

  • 18

    Dec

JPM

JPMorgan

$107.36

-2.23 (-2.03%)

, ORCL

Oracle

$48.84

-0.68 (-1.37%)

16:20
11/14/18
11/14
16:20
11/14/18
16:20
Hot Stocks
Berkshire Hathaway adds to Apple, takes JPMorgan stake in Q3 »

Warren Buffett's…

JPM

JPMorgan

$107.36

-2.23 (-2.03%)

ORCL

Oracle

$48.84

-0.68 (-1.37%)

PNC

PNC Financial

$134.22

-1.495 (-1.10%)

TRV

Travelers

$123.01

-3.82 (-3.01%)

SNY

Sanofi

$45.08

0.18 (0.40%)

WMT

Walmart

$101.58

-1.37 (-1.33%)

AAPL

Apple

$186.81

-5.42 (-2.82%)

BAC

Bank of America

$27.23

-0.53 (-1.91%)

USB

U.S. Bancorp

$54.01

0.32 (0.60%)

GS

Goldman Sachs

$202.43

-2.49 (-1.22%)

DAL

Delta Air Lines

$56.43

-0.38 (-0.67%)

PSX

Phillips 66

$95.59

0.78 (0.82%)

WFC

Wells Fargo

$52.15

-0.59 (-1.12%)

AAL

American Airlines

$38.10

0.32 (0.85%)

CHTR

Charter

$320.65

-4.01 (-1.24%)

UAL

United Continental

$91.79

-0.81 (-0.87%)

KO

Coca-Cola

$49.77

-0.09 (-0.18%)

KHC

Kraft Heinz

$52.63

-0.75 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 05

    Dec

  • 06

    Dec

  • 16

    Jan

  • 28

    Jan

  • 12

    Feb

  • 26

    Feb

  • 03

    Mar

  • 11

    Mar

  • 22

    Mar

  • 12

    Apr

  • 12

    Apr

  • 28

    Apr

  • 13

    Jul

  • 17

    Jul

  • 12

    Oct

  • 16

    Oct

SQ

Square

$69.85

-1.96 (-2.73%)

16:20
11/14/18
11/14
16:20
11/14/18
16:20
Initiation
Square initiated  »

Square initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 12

    Dec

  • 18

    Dec

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
11/14/18
11/14
16:20
11/14/18
16:20
Options
Closing CBOE SPX and VIX Index summary for November 14th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFS

Smart & Final Stores

$4.96

-0.2 (-3.88%)

16:20
11/14/18
11/14
16:20
11/14/18
16:20
Hot Stocks
Breaking Hot Stocks news story on Smart & Final Stores »

Smart & Final Stores…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

TSS

TSYS

$87.77

-2.06 (-2.29%)

16:19
11/14/18
11/14
16:19
11/14/18
16:19
Initiation
TSYS initiated  »

TSYS initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NR

Newpark Resources

$7.75

0.12 (1.57%)

16:19
11/14/18
11/14
16:19
11/14/18
16:19
Hot Stocks
Newpark Resources expands securities repurchase program to $100M »

Newpark Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDTI

CDTi

$1.49

-0.03 (-1.97%)

16:19
11/14/18
11/14
16:19
11/14/18
16:19
Hot Stocks
CDTi announces plan to delist from Nasdaq, deregister common stock »

CDTi Advanced Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPY

Brookfield Property

$18.76

-0.46 (-2.39%)

, FCE.A

Forest City

$25.25

0.11 (0.44%)

16:19
11/14/18
11/14
16:19
11/14/18
16:19
Conference/Events
Forest City to host special shareholder meeting »

Special Shareholder…

BPY

Brookfield Property

$18.76

-0.46 (-2.39%)

FCE.A

Forest City

$25.25

0.11 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.